FOOD, MICROBES, AND THE MIND: INTERVENTIONS AND TECH-FOR-HEALTH IMPLICATIONS

Research objectives: To synthesise recent evidence on microbiome-brain relationships across Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, autism spectrum disorder, depression and schizophrenia; to summarise therapeutic strategies (diet, probiotics/prebiotics, psychobiotics, faecal microbiota transplantation) and biological mechanisms; and to outline translational considerations relevant to technology and society. Methods: Structured narrative review with a PRISMA-style workflow. Sources: PubMed/MEDLINE and Web of Science (Core Collection), plus handsearch/citation chasing (English/Polish; 1 Jan 2013–31 Mar 2025). Ten authors performed duplicate screening and data charting. Heterogeneity precluded meta-analysis. Included n=21 studies after databases identified n=1,500 records, duplicates n=540, screened n=960, and full texts assessed n=252 (databases) and n=48 from other sources; the reference list also cites background/methodological works not counted in PRISMA. Key findings: Across conditions, a consistent signal is loss of short-chain-fatty-acid (SCFA)–producing taxa, increased intestinal permeability and immune activation. High-fibre/polyphenol diets and multi-strain probiotics/prebiotics show the clearest-though modest-improvements in inflammatory markers and selected mood/quality-of-life outcomes; cognitive effects are mixed. Psychobiotics show preliminary benefits; faecal microbiota transplantation remains experimental in neurology. Mechanistic strands include SCFAs, tryptophan/kynurenine metabolism, vagal signalling and HPA-axis modulation. Conclusions: The gut microbiome is a modifiable contributor to brain health. Low-risk dietary optimisation is warranted, and probiotic use should be strain-specific. Priorities include adequately powered, preregistered trials with harmonised microbiome pipelines and mechanistic endpoints, plus evaluation of precision-nutrition and data-driven decision support under robust privacy governance.

Authors

Institutions

Publication Details

Journal
International Journal of Innovative Technologies in Social Science
Published
2025-09-30
DOI
https://doi.org/10.31435/ijitss.3(47).2025.3841
Primary Topic
Gut microbiota and health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

FOOD, MICROBES, AND THE MIND: INTERVENTIONS AND TECH-FOR-HEALTH IMPLICATIONS

Julia Lipiec, Weronika Sobota, Przemysław Piskorz, Konrad Kotte et al.
International Journal of Innovative Technologies in Social Science
Gut microbiota and health
article

FOOD, MICROBES, AND THE MIND: INTERVENTIONS AND TECH-FOR-HEALTH IMPLICATIONS

Julia Lipiec, Weronika Sobota, Przemysław Piskorz, Konrad Kotte, Patryk Biesaga, Daria Litworska-Sójka, Olaf Jadanowski, Kamil Łebek, Bartosz Komsta, Wojciech Pabis
article en

Abstract

Research objectives: To synthesise recent evidence on microbiome-brain relationships across Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, autism spectrum disorder, depression and schizophrenia; to summarise therapeutic strategies (diet, probiotics/prebiotics, psychobiotics, faecal microbiota transplantation) and biological mechanisms; and to outline translational considerations relevant to technology and society. Methods: Structured narrative review with a PRISMA-style workflow. Sources: PubMed/MEDLINE and Web of Science (Core Collection), plus handsearch/citation chasing (English/Polish; 1 Jan 2013–31 Mar 2025). Ten authors performed duplicate screening and data charting. Heterogeneity precluded meta-analysis. Included n=21 studies after databases identified n=1,500 records, duplicates n=540, screened n=960, and full texts assessed n=252 (databases) and n=48 from other sources; the reference list also cites background/methodological works not counted in PRISMA. Key findings: Across conditions, a consistent signal is loss of short-chain-fatty-acid (SCFA)–producing taxa, increased intestinal permeability and immune activation. High-fibre/polyphenol diets and multi-strain probiotics/prebiotics show the clearest-though modest-improvements in inflammatory markers and selected mood/quality-of-life outcomes; cognitive effects are mixed. Psychobiotics show preliminary benefits; faecal microbiota transplantation remains experimental in neurology. Mechanistic strands include SCFAs, tryptophan/kynurenine metabolism, vagal signalling and HPA-axis modulation. Conclusions: The gut microbiome is a modifiable contributor to brain health. Low-risk dietary optimisation is warranted, and probiotic use should be strain-specific. Priorities include adequately powered, preregistered trials with harmonised microbiome pipelines and mechanistic endpoints, plus evaluation of precision-nutrition and data-driven decision support under robust privacy governance.

International Journal of Innovative Technologies in Social ScienceVol. 5(3(47))
Military Hospital (PK), University of Bydgoszcz (PL), St. Luke's Hospital (US), Wojskowy Instytut Medycyny Lotniczej (PL), Central Clinical Hospital (PL), Wojewódzki Szpital Zespolony im. Jędrzeja Śniadeckiego (PL)
Openalex Percentile: Top 74%
Gut microbiota and health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.